Cargando…
A Phase I Trial of VEGF-A Inhibition Combined with PD-L1 Blockade for Recurrent Glioblastoma
PURPOSE: The treatment of glioblastoma (GBM) poses challenges. The use of immune checkpoint inhibition (ICI) has been disappointing as GBM is characterized by low mutational burden and low T-cell infiltration. The combination of ICI with other treatment modalities may improve efficacy. PATIENT AND M...
Autores principales: | Chiu, Daniel, Qi, Jingjing, Thin, Tin Htwe, Garcia-Barros, Monica, Lee, Brian, Hahn, Mary, Mandeli, John, Belani, Puneet, Nael, Kambiz, Rashidipour, Omid, Ghatan, Saadi, Hadjipanayis, Constantinos G., Yong, Raymund L., Germano, Isabelle M., Brody, Rachel, Tsankova, Nadejda M., Gnjatic, Sacha, Kim-Schulze, Seunghee, Hormigo, Adília |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035521/ https://www.ncbi.nlm.nih.gov/pubmed/36968223 http://dx.doi.org/10.1158/2767-9764.CRC-22-0420 |
Ejemplares similares
-
Tumoral and immune heterogeneity in an anti-PD-1-responsive glioblastoma: a case study
por: Restrepo, Paula, et al.
Publicado: (2020) -
U-Net Based Segmentation and Characterization of Gliomas
por: Kihira, Shingo, et al.
Publicado: (2022) -
MRI Radiomic Features to Predict IDH1 Mutation Status in Gliomas: A Machine Learning Approach using Gradient Tree Boosting
por: Sakai, Yu, et al.
Publicado: (2020) -
Multiparametric MRI texture analysis in prediction of glioma biomarker status: added value of MR diffusion
por: Kihira, Shingo, et al.
Publicado: (2021) -
Widely metastatic glioblastoma with BRCA1 and ARID1A mutations: a case report
por: Umphlett, Melissa, et al.
Publicado: (2020)